Search research articles
Contact Us
Filters
Showing results (1-10 of 3) with videos related to
Page
of 1
Sort By:
Vaccine
|
February 5, 2016
A phase 3, randomized, active-controlled study to assess the safety and tolerability of meningococcal serogroup B vaccine bivalent rLP2086 in healthy adolescents and young adults
Lars Ostergaard, Gregg H Lucksinger, Judith Absalon, et al.
The Lancet. HIV
|
September 24, 2016
Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trial
Steffen Leth, Mariane H Schleimann, Sara K Nissen, et al.
Plos Pathogens
|
September 18, 2015
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
Ole S Søgaard, Mette E Graversen, Steffen Leth, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 3) with videos related to
Sort By:
Page
of 1
Vaccine
|
February 5, 2016
A phase 3, randomized, active-controlled study to assess the safety and tolerability of meningococcal serogroup B vaccine bivalent rLP2086 in healthy adolescents and young adults
Lars Ostergaard, Gregg H Lucksinger, Judith Absalon, et al.
The Lancet. HIV
|
September 24, 2016
Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trial
Steffen Leth, Mariane H Schleimann, Sara K Nissen, et al.
Plos Pathogens
|
September 18, 2015
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
Ole S Søgaard, Mette E Graversen, Steffen Leth, et al.
Page
of 1